Cardiac amyloidosis treated with an implantable cardioverter defibrillator and subcutaneous array lead system: Report of a case and literature review

Clinical Cardiology

Volumn 32, Issue 8, 2009, Pages

  Dhoble, Abhijeet ^a   Khasnis, Atul ^a   Olomu, Adesuwa ^a   Thakur, Ranjan ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOMEGALY; CASE REPORT; CONGESTIVE HEART FAILURE; DEFIBRILLATION; DEFIBRILLATOR; ELECTRODE; FEMALE; HEART AMYLOIDOSIS; HEART EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; SUDDEN DEATH; TRANSTHORACIC ECHOCARDIOGRAPHY;

AMYLOIDOSIS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; FEMALE; HEART DISEASES; HUMANS; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 69249098586     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20389     Document Type: Article

References (12)

1. Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: A comprehensive review. Arch Intern Med. 2006;166:1805-1813.
2. Falk RH, Rubinow A, Cohen AS. Cardiac arrhythmias in systemic amyloidosis: Correlation with echocardiographic abnormalities. J Am Coll Cardiol. 1984;3:107-113. (Pubitemid 14219960)
3. Wright JR, Calkins E. Clinical-pathologic differentiation of common amyloid syndromes. Medicine (Baltimore). 1981;60:429-448. (Pubitemid 12207236)
4. Chamarthi B, Dubrey SW, Cha K, Skinner M, Falk RH. Features and prognosis of exertional syncope in light chain associated AL cardiac amyloidosis. Am J Cardiol. 1997;80:1242-1245. (Pubitemid 27467425)
5. Kühlkamp V, Khalighi K, Dörnberger V, Ziemer G. Single incision and single element Array electrode to lower the defibrillation threshold. Ann Thorac Surg. 1997;64:1177-1179. (Pubitemid 27497411)
6. Mainigi S, Callans D. How to manage patients with high defibrillation threshold. J Heart Rhythm Soc. 2006;3:492-495.
7. Kühlkamp V, Dörnberger V, Mewis C, Seipel L. Comparison of the efficacy of a subcutaneous array electrode with a subcutaneous patch electrode, a prospective randomized study. Int J Cardiol. 2001;78:247-256. (Pubitemid 32497183)
8. Jordaens L, Vertongen P, Van-Belleghem Y. A subcutaneous lead array for implantable cardioverter defibrillators. PACE. 1993;16:1429-1432. (Pubitemid 23209215)
9. Higgins SL, Alexander DC, Kuypers CJ, Brewster SA. The subcutaneous array: A new lead adjunct for the transvenous ICD to lower defibrillation threshold. PACE. 1995;18:1540-1548.
10. Saksena S, Breithardt G, Dorian P, et al. Non-pharmacological therapy for malignant ventricular arrhythmias: Implantable defibrillator trials. Prog Cardiovasc Dis. 1996;38:429-444. (Pubitemid 26169425)
11. Kühlkamp V, Dörnberger V, Khalighi K, et al. Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold. Pacing Clin Electrophysiol. 21(12): 2596-2605.
12. Lang DJ, Heil JE, Hahn SJ, Lindstrom CC, Derfus DL. Implantable cardioverter defibrillator lead technology: Improved performance and lower defibrillation thresholds. Pacing Clin Electrophysiol. 1995;18:548-559.